Page 43 - Unity Lab Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thermo Fisher Scientific Inc. the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently introduced Bigfoot Spectral Cell Sorter and approximately 40 employees will become part of Thermo Fisher's Biosciences business. Propel Labs will continue to operate as a separate ...

Thermo Fisher Scientific Invests $25 Million to Support Black Communities and Businesses in the U.S. Thermo Fisher Scientific Inc. the world leader in serving science, today announced it has committed to investing up to $25 million in minority-serving financial institutions. “Unequal access to capital is hurting Black-owned businesses, Black entrepreneurs and Black communities in the United States ,” said Marc N. Casper chairman, president and chief executive officer of Thermo Fisher Scientific. “Minority-serving … Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Thermo Fisher Scientific Partners with Mindray on Clinical Chemistry Analyzers for use with Drugs of Abuse Immunoassays February 9, 2021 GMT Thermo Fisher Scientific (PRNewsfoto/Thermo Fisher Scientific) FREMONT, Calif., Feb. 9, 2021 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced a partnership with Mindray, a leading global developer, manufacturer and supplier of medical devices, to make available to customers two clinical chemistry analyzers in the Unite...

Share this article Share this article CARLSBAD, Calif., Feb. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compatible with the Amplitude platform. The high-throughput solution enables clinical and public health laboratories to efficiently test up to 8,000 COVID-19 samples a day with fewer staffing requirements and a reliable supply of kits, reagents and consumables. The highly automated Amplitude platform is a molecular diagnostic system that allows labs to increase...

Share this article Share this article WALTHAM, Mass., Feb. 3, 2021 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exclusive commercial access to Thermo Fisher's Gibco CTS Dynabeads CD3/CD28. The agreement will support the clinical development and commercial manufacturing of leading CAR-T (Chimeric Antigen Receptor T-Cells) therapies in China, including JW Therapeutics' lead product relmacabtagene autoleucel ("relma-cel"). Relma-cel is an anti-CD19 CAR-T therapy for thi...